Skip to main content

54 323 Pill - yellow round, 6mm

Pill with imprint 54 323 is Yellow, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Hikma Pharmaceuticals PLC.

Methotrexate is used in the treatment of Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Polyarticular Juvenile Idiopathic Arthritis; Breast Cancer; Rheumatoid Arthritis and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 323

Methotrexate sodium 2.5 mg 54 323
Methotrexate sodium 2.5 mg 54 323 Front
Methotrexate sodium 2.5 mg 54 323 Back
Methotrexate sodium 2.5 mg 54 323
Methotrexate sodium 2.5 mg 54 323

Methotrexate Sodium

Imprint
54 323
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Hikma Pharmaceuticals PLC
Inactive Ingredients
lactose anhydrous, magnesium stearate, corn starch, sodium hydroxide, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00054-4550 Roxane Laboratories, Inc.
00054-8550 Roxane Laboratories, Inc.

Get help with Imprint Code FAQs.

Related images for "54 323"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.